|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01548 GENSCRIPT BIO
Nominal 
16.050 -0.180 (-1.109%) | 2025/06 - Interim USD(K$) | %Chg (Compare to Interim) | 2024/06 USD(K$) | 2023/06 USD(K$) | 2022/06 USD(K$) | 2021/06 USD(K$) | |
| Turnover | 518,773 | -7.588% | 561,371 | 391,311 | 309,589 | 229,568 |
| Cost of Sales | (198,142) | -22.109% | (254,385) | (216,263) | (141,091) | (90,949) |
| Gross Profit | 320,631 | 4.445% | 306,986 | 175,048 | 168,498 | 138,619 |
| 2025/06 - Interim USD(K$) | %Chg (Compare to Interim) | 2024/06 USD(K$) | 2023/06 USD(K$) | 2022/06 USD(K$) | 2021/06 USD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (13,366) | -91.369% | (154,852) | (37,098) | (47,359) | (2,831) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (193,406) | -- | 0 | (230) | 0 | 0 | |
| Profit / (Loss) before Taxation | (119) | -99.942% | (205,588) | (244,653) | (229,776) | (150,224) | |
| Taxation | (24,428) | 143.234% | (10,043) | (1,104) | (3,813) | (5,925) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (915) | -- | 40,516 | 152,176 | 98,082 | 65,027 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (25,462) | -85.460% | (175,115) | (93,581) | (135,507) | (91,122) | |
| 2025/06 - Interim USD(K$) | %Chg (Compare to Interim) | 2024/06 USD(K$) | 2023/06 USD(K$) | 2022/06 USD(K$) | 2021/06 USD(K$) | |
| Net Finance Costs / (Income) | 9,202 | -35.316% | 14,226 | (12,403) | 84 | 378 |
| Depreciation & Amortisation | 34,892 | -13.409% | 40,295 | 35,522 | 30,020 | 23,006 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| EPS (cts) | -1.180 | -85.732% | -8.270 | -4.440 | -6.480 | -4.610 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 2.026 | -- | 0.571 | 0.639 | -- | 0.485 |
| Remarks: | Real time quote last updated: 28/10/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | USD -25,462 |
| %Change | -85.460% |
| EPS / (LPS) | USD -0.012 |
| NBV Per Share ($) | USD 2.026 |